financetom
Business
financetom
/
Business
/
Delta Air Lines Q3 adj EPS beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Delta Air Lines Q3 adj EPS beats estimates
Oct 9, 2025 4:16 AM

Overview

* Delta's Q3 2025 operating revenue reached $16.67 bln

* Adjusted EPS for Q3 2025 was $1.71, ahead of analysts's expectations.

* Company expects Q4 operating margin of 10.5% to 12%, adjusted EPS of $1.60 to $1.90

Outlook

* Delta expects December qtr operating margin of 10.5% to 12%

* Company projects December qtr adj EPS of $1.60 to $1.90

* Delta anticipates full-year EPS of approximately $6

* Company forecasts full-year free cash flow of $3.5 bln to $4 bln

Result Drivers

* DIVERSE REVENUE STREAMS - Delta's diversified revenue base contributed 60% of total revenue and grew double-digits yr/yr, with premium and loyalty revenue up 9%

* DOMESTIC REVENUE GROWTH - Domestic passenger revenue grew 5% yr/yr, driven by corporate sales acceleration and premium cabin strength

* AMERICAN EXPRESS PARTNERSHIP - American Express remuneration grew 12% yr/yr, driven by co-brand spend growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $16.67

Revenue bln

Q3 adj Beat $1.71 $1.53

EPS

Q3 Net $1.41

Income bln

Q3 10.10%

Operatin

g Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the airlines peer group is "buy"

* Wall Street's median 12-month price target for Delta Air Lines Inc ( DAL ) is $68.00, about 16% above its October 8 closing price of $57.12

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
 Evofem Biosciences Q3 net sales rise
 Evofem Biosciences Q3 net sales rise
Nov 13, 2025
Overview * Evofem Q3 net sales rise 10% yr/yr to $5.0 mln * Company posts $1.0 mln operating income, reversing prior yr $2.4 mln loss * Operating expenses fall 42% yr/yr, aiding profit turnaround Outlook * Company aims to reduce manufacturing costs by 50% for PHEXX and SOLOSEC * SOLOSEC submitted for marketing approval in the UAE * Company did...
Virgin Galactic Q3 revenue misses analyst expectations
Virgin Galactic Q3 revenue misses analyst expectations
Nov 13, 2025
Overview * Virgin Galactic ( SPCE ) Q3 revenue misses analyst expectations, with a slight year-over-year decrease * Net loss for Q3 improves to $64 mln, driven by lower operating expenses * Company maintains strong cash position with $424 mln in cash and equivalents, as of September 30, 2025. Outlook * Virgin Galactic expects free cash flow of $(90) mln...
Oscar Health Insider Sold Shares Worth $5,954,764, According to a Recent SEC Filing
Oscar Health Insider Sold Shares Worth $5,954,764, According to a Recent SEC Filing
Nov 13, 2025
04:23 PM EST, 11/13/2025 (MT Newswires) -- Mario Schlosser, Director, President of Technology & CTO, on November 11, 2025, sold 391,482 shares in Oscar Health ( OSCR ) for $5,954,764. Following the Form 4 filing with the SEC, Schlosser has control over a total of 501,148 Class A common shares of the company, with 501,148 shares held directly. SEC Filing:...
Supply chain firm Repositrak's Q1 revenue up 10%, slightly misses estimates
Supply chain firm Repositrak's Q1 revenue up 10%, slightly misses estimates
Nov 13, 2025
Overview * Repositrak fiscal Q1 2026 revenue rises 10%, slightly missing estimates * Adjusted EPS for fiscal Q1 misses analyst expectations * Net income for fiscal Q1 increases 9% to $1.82 mln Outlook * Company plans to redeem all preferred shares by December 2026 * ReposiTrak ( TRAK ) highlights automation as a key driver for future profitability * Company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved